Inspire Medical Systems (STU:2DR) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Inspire Medical Systems EBITDA Margin % Related Terms
Inspire Medical Systems EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:2DR vs BFLY, ATEC, TNDM: EBITDA Margin % Comparison
For the Medical Devices subindustry, Inspire Medical Systems's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Inspire Medical Systems EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Inspire Medical Systems's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Inspire Medical Systems's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inspire Medical Systems (STU:2DR) has a EBITDA Margin % of 1.95% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Inspire Medical Systems and its competitors. According to the industry distribution chart, Inspire Medical Systems ranks #389 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 47.7%.
Is Inspire Medical Systems' EBITDA Margin % too high?
Inspire Medical Systems' current EBITDA Margin % is 1.95%. The Medical Devices & Instruments industry median EBITDA Margin % is 7.48. Inspire Medical Systems' value of 1.95% is 73.9% below this industry median. Based on the distribution chart, Inspire Medical Systems ranks #389 out of 816 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Inspire Medical Systems has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Inspire Medical Systems' EBITDA Margin % compare to BFLY and ATEC?
According to the Medical Devices & Instruments industry distribution chart, Inspire Medical Systems ranks #389 out of 816 companies for EBITDA Margin %. This puts Inspire Medical Systems in the upper half of its industry. The industry median EBITDA Margin % is 7.48. Inspire Medical Systems' value of 1.95% is 73.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Inspire Medical Systems's current EBITDA Margin % of 1.95% is 73.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Inspire Medical Systems and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Inspire Medical Systems's current EBITDA Margin % is 1.95%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inspire Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, Inspire Medical Systems (STU:2DR) is currently considered Possible Value Trap. The stock's GF Value™ is €190.61, compared to a current price of €37.80 — trading 80.2% below its estimated fair value. The current EBITDA Margin % is 1.95% and 73.9% below the Medical Devices & Instruments industry median of 7.48. Inspire Medical Systems' overall GF Score™ is 55/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Inspire Medical Systems (STU:2DR), the current EBITDA Margin % is 1.95% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Inspire Medical Systems (STU:2DR) Overvalued in 2026?
Based on GuruFocus' analysis, Inspire Medical Systems stock appears to be undervalued.
The current stock price of €37.80 is trading 80.2% below its estimated GF Value™ of €190.61.
GuruFocus considers Inspire Medical Systems to be Possible Value Trap.
Key valuation signals for STU:2DR:
EBITDA Margin %: 1.95%
GF Value™: €190.61 vs. price of €37.80 (80.2% below fair value)
Industry Position: 73.9% below the Medical Devices & Instruments median (#389 of 816)
No single metric tells the full story. See the STU:2DR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
55GF Score
Get the complete analysis for STU:2DR
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:2DR has been successfully added to your 
